Background/Purpose: Current guidelines do not provide specific recommendations regarding the timing of endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute cholangitis (AC) concurrent with acute gallstone pancreatitis (AGP). This study evaluated the impact of ERCP timing on clinical outcomes.Methods: A total of 144 patients diagnosed with AC concurrent with AGP between March 2019 and February 2024 were included in the study. Patients were classified into two groups: urgent ERCP group (ERCP ≤ 24 h) and non‐urgent ERCP group (ERCP 24–72 h). Clinical outcomes were compared using propensity score matching (PSM) analysis.Results: After PSM, two well‐balanced groups of 55 patients were created. The median ERCP time was 18 (13–21) hours in the urgent group and 41 (36–54) hours in the non‐urgent group. There was no significant difference in composite outcomes, including in‐hospital mortality, prolonged hospital stay, severe pancreatitis, or late localized/systemic complications of pancreatitis [11 (20%) vs. 16 (29.1%); p = 0.268]. Additionally, no significant difference was observed between the groups regarding prolonged hospital stay (p = 0.506), ICU admission (p = 0.680), or in‐hospital mortality (p = 0.161).Conclusions: Urgent ERCP within 24 h does not significantly improve clinical outcomes compared to ERCP performed within 24–72 h in patients with AC and AGP.
31 January 2022 in The Journal of Infection in Developing Countries
Introduction: Effectiveness of hydroxychloroquine against SARS-CoV-2 has been highly controversial. In our research, we aimed to investigate the effects of hydroxychloroquine on disease outcomes in hospitalized patients with COVID-19. Methodology: A total of 393 hospitalized patients with COVID-19 were retrospectively assigned to the standard of care therapy group (n = 180) or the standard of care plus hydroxychloroquine group (n = 213). The standard of care therapy comprised favipiravir, low molecular weight heparin, acetylsalicylic acid. Status of oxygenation at baseline and on the seventh day, laboratory tests at baseline and at discharge were recorded. Length of hospital stay, administration of anti-inflammatory treatment, admission to the intensive care unit and 28th day mortality were set as primary endpoints. Results: There were no statistically significant differences between groups in terms of oxygen delivery route and mortality after seven days of treatment (p = 0.592). C-reactive protein levels of the standard of care plus hydroxychloroquine group were significantly lower than that of the standard of care group at discharge (p = 0.034). Patients in the standard of care plus hydroxychloroquine group had shorter hospital stay (p = 0.007). The standard of care plus hydroxychloroquine group was favored over standard of care group in terms of rate of intensive care unit admissions (21.7% vs. 10.8%; relative risk with 95% CI = 0.49 [0.31-0.80], p = 0.003). Conclusions: Hydroxychloroquine in addition to standard of care was associated with less intensive care unit admissions, early discharge and greater C-reactive protein reduction. There was no difference in 28-day mortality.
Objective: Hepatic steatosis commonly coexists with cardiometabolic risk factors, yet circadian blood pressure patterns in adults with hepatic steatosis remain incompletely characterized. This study aimed to describe ambulatory blood pressure patterns in adults with ultrasonographically detected moderate-to-severe hepatic steatosis. Methods: This single-center prospective observational study enrolled adults with grade 2 or 3 hepatic steatosis on abdominal ultrasonography between August 2023 and August 2024. All participants underwent 24-h ambulatory blood pressure monitoring after enrollment. Patients were classified as dipper or non-dipper according to nocturnal blood pressure decline, and clinical, biochemical, ultrasonographic, and ambulatory parameters were compared. Results: Among 137 patients, 43 (31.4%) had a dipper pattern and 94 (68.6%) had a non-dipper pattern. Grade 2 and grade 3 steatosis were present in 125 (91.2%) and 12 (8.8%) patients, respectively. In the exploratory multivariable analysis, age, sex, antihypertensive treatment, and ultrasonographic steatosis grade were not independently associated with non-dipping status. Ambulatory hypertension thresholds were met more often in the non-dipper group [72 (76.6%) vs. 25 (58.1%), p = 0.027]. Nocturnal hypertension was more frequent in the non-dipper group [72 (76.6%) vs. 22 (51.2%), p = 0.003]. The non-dipper group had higher 24-h systolic blood pressure [134.0 (122.0–145.0) vs. 130.0 (118.5–136.0) mmHg, p = 0.027]. The median nocturnal systolic blood pressure decline in the overall cohort was 6.0% [2.6–11.3], whereas daytime systolic and diastolic blood pressure values were comparable between groups. Conclusions: Non-dipping blood pressure was frequent in adults with moderate-to-severe hepatic steatosis. Ambulatory blood pressure monitoring provides a descriptive assessment of nocturnal blood pressure patterns in this selected hepatic steatosis cohort.
23 September 2025 in Intercontinental Journal of Emergency Medicine
Aims: The aim of this study was to investigate the relationship between fibroblast growth factor 21 (FGF-21) levels and coronary artery calcium (CAC) scores calculated using the Agatston method, and to evaluate the potential of FGF-21 as a non-invasive biomarker for the assessment of coronary artery calcification. Methods: A total of 54 adult individuals who had undergone coronary CT angiography within the past three months solely for cardiovascular risk assessment were prospectively included in the study. Serum FGF-21 levels were measured using the ELISA method, and CAC scores were determined via the Agatston scoring system. The relationship between FGF-21 levels and CAC scores was analyzed using Spearman’s correlation test. Results: A significant and strong positive correlation was observed between FGF-21 levels and CAC scores (r = 0.725, p < 0.001). Diabetes mellitus and hyperlipidemia were significantly associated with higher CAC scores (p = 0.006 and p = 0.024, respectively), whereas their associations with FGF-21 levels were not statistically significant (p = 0.065 and p = 0.104). No significant correlations were found between FGF-21 levels and other variables such as age, gender, hypertension, or biochemical parameters. Conclusion: The findings suggest that serum FGF-21 levels may be associated with coronary artery calcification and could serve as a non-invasive and easily applicable biomarker in individuals for coronary artery disease. FGF-21 may be particularly useful in clinical settings where access to advanced imaging modalities is limited.
30 September 2025 in Ankara Üniversitesi Tıp Fakültesi Mecmuası
Objectives: This study aimed to evaluate the prognostic performance of hematological parameters, including red cell distribution width (RDW) and neutrophil-to-lymphocyte ratio (NLR), in patients with acute cholangitis (AC). Materials and Methods: In this prospective study, 202 patients diagnosed with AC between December 2023 and August 2024 were included. The predictive performance of admission hematological parameters for clinical outcomes, including in-hospital mortality, bacteremia, need for inotropic support, prolonged hospital stay, intensive care unit (ICU) admission, and prolonged ICU stay, was assessed and compared. Results: Among the 202 patients, 16 (7.9%) died during hospitalization. Multivariate regression analysis identified RDW as an independent risk factor for in-hospital mortality (odds ratio [OR]: 2.25, 95% confidence interval [CI]: 1.48–3.42, p
26 December 2025 in Intercontinental Journal of Emergency Medicine
A significant method for managing asthma involves the use of interleukin-5 (IL-5) inhibitors such as mepolizumab. In this case, a 52-year-old female patient who developed hypertensive crisis, temporary blurred vision, headache and chest pain after mepolizumab treatment is presented. This case is particularly important as hypertensive crisis accompanied by blurred vision following mepolizumab treatment has not been previously demonstrated in the literature. We present the case of a 52-year-old patient who developed hypertensive crisis after mepolizumab treatment for severe asthma. The patient's clinical condition improved after antihypertensive treatment. The possible effects of inflammatory mediator inhibitors on the human immune system should be further investigated so that their negative effects can be detected at an early stage. We recommend blood pressure monitoring for the first 60 minutes after mepolizumab treatment.